312 related articles for article (PubMed ID: 26228294)
1. A convenient screening method to differentiate phenolic skin whitening tyrosinase inhibitors from leukoderma-inducing phenols.
Ito S; Wakamatsu K
J Dermatol Sci; 2015 Oct; 80(1):18-24. PubMed ID: 26228294
[TBL] [Abstract][Full Text] [Related]
2. A cell-based evaluation of human tyrosinase-mediated metabolic activation of leukoderma-inducing phenolic compounds.
Nishimaki-Mogami T; Ito S; Cui H; Akiyama T; Tamehiro N; Adachi R; Wakamatsu K; Ikarashi Y; Kondo K
J Dermatol Sci; 2022 Nov; 108(2):77-86. PubMed ID: 36567223
[TBL] [Abstract][Full Text] [Related]
3. Action of ellagic acid on the melanin biosynthesis pathway.
Ortiz-Ruiz CV; Berna J; Tudela J; Varon R; Garcia-Canovas F
J Dermatol Sci; 2016 May; 82(2):115-22. PubMed ID: 26899308
[TBL] [Abstract][Full Text] [Related]
4. [Leukoderma caused by chemicals: mechanisms underlying 4-alkyl/aryl-substituted phenols- and rhododendrol-induced melanocyte loss].
Nishimaki-Mogami T
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2015; (133):13-20. PubMed ID: 26821466
[TBL] [Abstract][Full Text] [Related]
5. Tyrosinase-Catalyzed Oxidation of the Leukoderma-Inducing Agent Raspberry Ketone Produces (E)-4-(3-Oxo-1-butenyl)-1,2-benzoquinone: Implications for Melanocyte Toxicity.
Ito S; Hinoshita M; Suzuki E; Ojika M; Wakamatsu K
Chem Res Toxicol; 2017 Mar; 30(3):859-868. PubMed ID: 28219012
[TBL] [Abstract][Full Text] [Related]
6. Human tyrosinase is able to oxidize both enantiomers of rhododendrol.
Ito S; Gerwat W; Kolbe L; Yamashita T; Ojika M; Wakamatsu K
Pigment Cell Melanoma Res; 2014 Nov; 27(6):1149-53. PubMed ID: 25130058
[TBL] [Abstract][Full Text] [Related]
7. Oxidation of 4-alkylphenols and catechols by tyrosinase: ortho-substituents alter the mechanism of quinoid formation.
Krol ES; Bolton JL
Chem Biol Interact; 1997 Apr; 104(1):11-27. PubMed ID: 9158692
[TBL] [Abstract][Full Text] [Related]
8. Tyrosinase-catalyzed oxidation of rhododendrol produces 2-methylchromane-6,7-dione, the putative ultimate toxic metabolite: implications for melanocyte toxicity.
Ito S; Ojika M; Yamashita T; Wakamatsu K
Pigment Cell Melanoma Res; 2014 Sep; 27(5):744-53. PubMed ID: 24903082
[TBL] [Abstract][Full Text] [Related]
9. Rhododendrol, a depigmentation-inducing phenolic compound, exerts melanocyte cytotoxicity via a tyrosinase-dependent mechanism.
Sasaki M; Kondo M; Sato K; Umeda M; Kawabata K; Takahashi Y; Suzuki T; Matsunaga K; Inoue S
Pigment Cell Melanoma Res; 2014 Sep; 27(5):754-63. PubMed ID: 24890809
[TBL] [Abstract][Full Text] [Related]
10. Melanogenesis-targeted anti-melanoma pro-drug development: effect of side-chain variations on the cytotoxicity of tyrosinase-generated ortho-quinones in a model screening system.
Riley PA; Cooksey CJ; Johnson CI; Land EJ; Latter AM; Ramsden CA
Eur J Cancer; 1997 Jan; 33(1):135-43. PubMed ID: 9071913
[TBL] [Abstract][Full Text] [Related]
11. Biochemical Mechanism of Rhododendrol-Induced Leukoderma.
Ito S; Wakamatsu K
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29439519
[No Abstract] [Full Text] [Related]
12. Tyrosinase-catalyzed metabolism of rhododendrol (RD) in B16 melanoma cells: production of RD-pheomelanin and covalent binding with thiol proteins.
Ito S; Okura M; Nakanishi Y; Ojika M; Wakamatsu K; Yamashita T
Pigment Cell Melanoma Res; 2015 May; 28(3):295-306. PubMed ID: 25713930
[TBL] [Abstract][Full Text] [Related]
13. Substantial evidence for the rhododendrol-induced generation of hydroxyl radicals that causes melanocyte cytotoxicity and induces chemical leukoderma.
Gabe Y; Miyaji A; Kohno M; Hachiya A; Moriwaki S; Baba T
J Dermatol Sci; 2018 Sep; 91(3):311-316. PubMed ID: 30005897
[TBL] [Abstract][Full Text] [Related]
14. A reactive ortho-quinone generated by tyrosinase-catalyzed oxidation of the skin depigmenting agent monobenzone: self-coupling and thiol-conjugation reactions and possible implications for melanocyte toxicity.
Manini P; Napolitano A; Westerhof W; Riley PA; d'Ischia M
Chem Res Toxicol; 2009 Aug; 22(8):1398-405. PubMed ID: 19610592
[TBL] [Abstract][Full Text] [Related]
15. Oxidative Oligomerization of DBL Catechol, a potential Cytotoxic Compound for Melanocytes, Reveals the Occurrence of Novel Ionic Diels-Alder Type Additions.
Sugumaran M; Umit K; Evans J; Muriph R; Ito S; Wakamatsu K
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32942764
[TBL] [Abstract][Full Text] [Related]
16. Tyrosinase-mediated formation of a reactive quinone from the depigmenting agents, 4-tert-butylphenol and 4-tert-butylcatechol.
Thörneby-Andersson K; Sterner O; Hansson C
Pigment Cell Res; 2000 Feb; 13(1):33-8. PubMed ID: 10761994
[TBL] [Abstract][Full Text] [Related]
17. The Metabolic Fate of ortho-Quinones Derived from Catecholamine Metabolites.
Ito S; Yamanaka Y; Ojika M; Wakamatsu K
Int J Mol Sci; 2016 Jan; 17(2):. PubMed ID: 26828480
[TBL] [Abstract][Full Text] [Related]
18. Chemical Reactivities of
Ito S; Sugumaran M; Wakamatsu K
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32846902
[TBL] [Abstract][Full Text] [Related]
19. Copper chelation by d-penicillamine alleviates melanocyte death induced by rhododendrol without inhibiting tyrosinase.
Nagatani K; Abe Y; Homma T; Fujii J; Suzuki T
Biochem Biophys Res Commun; 2023 Jun; 663():71-77. PubMed ID: 37119768
[TBL] [Abstract][Full Text] [Related]
20. Mechanistic aspects of the tyrosinase oxidation of hydroquinone.
Ramsden CA; Riley PA
Bioorg Med Chem Lett; 2014 Jun; 24(11):2463-4. PubMed ID: 24767847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
